Midlife Plasma AB and Latelife Risk of MCI/Dementia Supplemental Material
<p><b>Objective. </b>To evaluate the association between midlife plasma amyloid-beta (Aβ<sub>1-42</sub>, Aβ<sub>1-40</sub>, Aβ<sub>42</sub>:Aβ<sub>40</sub>) and risk of MCI and dementia.</p> <p>Plasma Aβ<sub>42</sub> and Aβ<sub>40</sub> were retrospectively measured using a fluorimetric bead-based immunoassay in a subsample of the Atherosclerosis Risk in Communities study (n=2284) at the third (1993-95, mean age=59.2±5.2, 57% female, 22% Black) and fifth in-person visits (2011-13, mean age=77.0±5.3). We investigated the relationship of plasma Aβ<sub>42</sub>, Aβ<sub>40</sub>, and Aβ<sub>42</sub>:Aβ<sub>40</sub> ratio measured in midlife, late-life, and the change from midlife to late-life, to risk of MCI, dementia, and combined MCI/dementia outcomes in late-life (from 2011-19). We used multinomial logistic regressions estimating relative risk ratios (RRR) of these cognitive outcomes vs cognitively normal adjusted for age, sex, education, site-race, APOE, hypertension, diabetes, and body mass index. Each doubling of midlife Aβ<sub>42</sub>:Aβ<sub>40</sub> was associated with 37% lower risk of MCI/dementia (RRR=0.63, 95% CI: 0.46, 0.87), but only up to approximately the median (spline model threshold 0.20). Every standard deviation increase in plasma Aβ<sub>42</sub> (10 pg/mL) was associated with 13% lower risk of MCI/dementia (RRR=0.87, 95% CI: 0.77, 0.98), whereas every standard deviation increase in plasma Aβ<sub>40</sub> (67 pg/mL) was associated with 15% higher risk of MCI/dementia (RRR=1.15, 95% CI: 1.01, 1.29). Associations were comparable, but slightly weaker statistically, when repeating models using late-life plasma Aβ predictors. Aβ<sub>42</sub> and Aβ<sub>40</sub> increased from midlife to late-life, but changes were not associated with cognitive outcomes. Midlife measurement of plasma Aβ may have utility as a blood-based biomarker indicative of risk for future cognitive impairment.</p>
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 0
- Harmonization
- 8
- Access
- 12
- Reuse readiness
- 0
- Engagement
- 4
Dataset details
- Repository
- dryad
- Published
- June 22, 2021
- License
- cc-zero
- DOI
- 10.5061/dryad.m0cfxpp33
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.